SS Innovations Announces Successful Completion of First Telesurgery Performed with the Company’s SSi Mantra Tele Surgeon Console
SS Innovations (Nasdaq: SSII) announced completion of its first telesurgery using the new SSi Mantra Tele Surgeon Console (TSC). On October 17, 2025, Dr. Sudhir Srivastava remotely performed a robotic-assisted coronary artery bypass from his residence in New Delhi on a patient about 185 miles away at Manipal Hospital in Jaipur.
The TSC is a compact, chair-based version of the SSi Mantra surgeon command center, designed for portability and smaller footprint so consoles can be placed in physician offices rather than full operating rooms. The device features lightweight glasses with magnified 3D view, magnetic sensor controls, and follows refinements made since its June 2024 showcase.
SS Innovations (Nasdaq: SSII) ha annunciato il completamento della sua prima telesurgery utilizzando il nuovo SSi Mantra Tele Surgeon Console (TSC). Il 17 ottobre 2025, il dottor Sudhir Srivastava ha eseguito a distanza una bypass coronarico assistita da robot dal suo domicilio a New Delhi su un paziente a circa 185 miglia di distanza presso il Manipal Hospital di Jaipur.
Il TSC è una versione compatta, basata sulla sedia, del centro di comando del chirurgo SSi Mantra, progettata per portabilità e impronta ridotta in modo che le console possano essere posizionate negli studi medici invece che nelle sale operatorie complete. Il dispositivo presenta occhiali leggeri con vista 3D ingrandita, controlli a sensori magnetici, e segue i miglioramenti apportati dai progressi mostrati nel giugno 2024.
SS Innovations (Nasdaq: SSII) anunció la finalización de su primera telesurgery utilizando el nuevo SSi Mantra Tele Surgeon Console (TSC). El 17 de octubre de 2025, el Dr. Sudhir Srivastava realizó de forma remota un bypass coronario asistido por robot desde su residencia en Nueva Delhi sobre un paciente a aproximadamente 185 millas de distancia en el Manipal Hospital de Jaipur.
El TSC es una versión compacta, basada en silla, del centro de mando del cirujano SSi Mantra, diseñada para portabilidad y una huella menor para que las consolas puedan ubicarse en consultorios médicos en lugar de en quirófanos completos. El dispositivo cuenta con gafas ligeras con vista 3D ampliada, controles con sensores magnéticos, y sigue los refinamientos realizados desde su exhibición de junio de 2024.
SS Innovations (나스닥: SSII)은 새로운 SSi Mantra Tele Surgeon Console (TSC)를 사용한 첫 번째 telesurgery의 완료를 발표했습니다. 2025년 10월 17일에 Sudhir Srivastava 박사는 뉴 델리의 자택에서 Jaipur의 Manipal Hospital에 약 185마일 떨어진 환자에게 로봇 보조 관상동맥 우회술을 원격으로 수행했습니다.
TSC는 SSi Mantra 외과 의사 지휘 센터의 의자형 버전으로 휴대성과 더 작은 차지 공간을 위해 설계되어 의사 진료실에 콘솔을 배치할 수 있도록 했습니다. 이 기기는 가벼운 안경과 확대된 3D 화면, 자석 센서 컨트롤을 특징으로 하며 2024년 6월 시연 이후의 개선점을 반영합니다.
SS Innovations (Nasdaq: SSII) a annoncé l'achèvement de sa première telesurgery utilisant le nouveau SSi Mantra Tele Surgeon Console (TSC). Le 17 octobre 2025, le Dr Sudhir Srivastava a réalisé à distance une dérivation coronarienne assistée par robot depuis son domicile à New Delhi sur un patient à environ 185 miles de distance à l'hôpital Manipal de Jaipur.
Le TSC est une version compacte, assise, du centre de commande du chirurgien SSi Mantra, conçue pour la portabilité et une empreinte plus petite afin que les consoles puissent être placées dans les cabinets médicaux plutôt que dans les salles d'opération complètes. L'appareil dispose de lunettes légères avec une vue 3D agrandie, de commandes à capteurs magnétiques, et suit les améliorations apportées depuis sa démonstration de juin 2024.
SS Innovations (Nasdaq: SSII) kündigte den Abschluss seiner ersten Telesurgery mit dem neuen SSi Mantra Tele Surgeon Console (TSC) an. Am 16. Oktober 2025 führte Dr. Sudhir Srivastava remote eine roboterassistierte Koronararterien-Bypass-Operation von seinem Wohnort in Neu-Delhi bei einem Patienten in etwa 185 Meilen Entfernung im Manipal Hospital in Jaipur durch.
Der TSC ist eine kompakte, sesselbasierte Version des SSi Mantra-Chirurgen-Kommandocenters, konzipiert für Tragbarkeit und eine kleinere Stellfläche, damit Konsolen in Arztpraxen statt in Operationsräumen platziert werden können. Das Gerät verfügt über leichte Brillen mit vergrößerter 3D-Ansicht, magnetische Sensorsteuerungen, und baut auf Verbesserungen auf, die seit seiner Vorstellung im Juni 2024 vorgenommen wurden.
SS Innovations (بورصة ناسداك: SSII) أعلنت إتمام أول telesurgery باستخدام وحدة التحكم الجراحي عن بُعد الجديدة SSi Mantra Tele Surgeon Console (TSC). في 17 أكتوبر 2025 قام الدكتور Sudhir Srivastava بتنفيذ جراحة مجازة شريانية تاجية بالروبوت عن بُعد من مقر إقامته في نيودلهي على مريض يبعد نحو 185 ميلاً عن المستشفى مانابال في Jaipur.
TSC هو نسخة مدمجة قائمة على المقعد من مركز قيادة الجراح SSi Mantra، مصممة للحمل والتنقل وبصمة أصغر لكي يمكن وضع وحدات التحكم في مكاتب الأطباء بدلاً من غرف العمليات الكاملة. الجهاز يتميز بنظارات خفيفة مع عرض ثلاثي الأبعاد مكبر، وتحكمات في مستشعرات مغناطيسية، ويتبع التحسينات التي أُجريت منذ عرض يونيو 2024.
- First telesurgery completed on October 17, 2025
- Remote procedure distance demonstrated: 185 miles (New Delhi to Jaipur)
- Smaller footprint enables placement in physicians' offices
- None.
Insights
Successful first remote robotic coronary bypass using the compact SSi Mantra Tele Surgeon Console shows a functional product milestone and operational proof of concept.
SS Innovations executed a remote robotic assisted coronary artery bypass on
The business mechanism is clear: the TSC aims to extend surgical expertise to locations outside traditional operating rooms by lowering space and equipment needs. The announcement demonstrates an operational end-to-end use case rather than a lab prototype, which is material for adoption discussions because it evidences actual clinical deployment.
Key dependencies and risks are evident from disclosed facts: reliable connectivity is required for operation, and the example is a single successful procedure performed by the company CEO. These facts limit conclusions about scalability, regulatory clearance, routine safety, and reproducibility across different surgeons, hospitals, and network conditions.
Concrete items to watch in the near term include documentation of additional clinical cases, any stated regulatory milestones for the TSC, formal safety and outcomes data versus standard practice, and broader deployment beyond a single-physician use case; expect such signals over the next 6–18 months.
Compact New Console Facilitates Performance of Telesurgeries from a Wide Range of Locations, including Physicians’ Offices
FORT LAUDERDALE, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the successful completion of the first telesurgery performed with the Company’s SSi Mantra Tele Surgeon Console (the “TSC”). The TSC is a compact self-contained chair-based version of the larger SSi Mantra surgeon command center that enables portability, requires less space, and facilitates the performance of telesurgeries from a wide range of settings including physician offices.
The Company first showcased this disruptive innovation at the Society of Robotic Surgery Meeting held in Orlando in June 2024 and since then has made a number of technological refinements to the TSC. On October 17, 2025, Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, utilized the TSC for the first time to remotely perform a robotic assisted coronary artery bypass procedure from his residence in New Delhi, India on a patient located approximately 185 miles away at Manipal Hospital in Jaipur, India. This milestone demonstrates the benefits of the TSC’s compact design, which enables the provision of surgical expertise from the office of any physician without requiring the resources of an entire operating room.
The SSi Mantra Tele Surgeon Console
Dr. Srivastava commented, “We believe that the SSi Mantra Tele Surgeon Console will offer significant advantages for telesurgery applications in the future and promote greater patient access to surgical expertise. The TSC is a compact, self-contained chair with inbuilt electronics, supported by lightweight glasses and magnified three-dimensional view capabilities as well as magnetic sensor-based controls. The TSC has a smaller footprint compared to our standard surgeon command center, providing hospital networks with flexibility to place consoles in the offices of surgical experts without tying up entire operating rooms. As long as connectivity is available, we believe that telesurgery and physician expertise can be extended from anywhere using the TSC.”
About SS Innovations
SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company’s website at ssinnovations.com or LinkedIn for more information and updates.
About the SSi Mantra
The SSi Mantra surgical robotic system is a user-friendly, modular, multi-arm system with many advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. A vision cart provides the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery. The SSi Mantra has been clinically validated in India in more than 100 different types of surgical procedures.
Forward Looking Statements
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SS Innovations’ future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
Investor Contact:
The Equity Group
Kalle Ahl, CFA
T: (303) 953-9878
kahl@theequitygroup.com
Devin Sullivan, Managing Director
T: (212) 836-9608
dsullivan@theequitygroup.com
Media Contact:
RooneyPartners LLC
Kate Barrette
T: (212) 223-0561
kbarrette@rooneypartners.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f255ad33-4c27-4da0-92fa-1a07b071ee7a
FAQ
When did SS Innovations (SSII) complete its first telesurgery with the SSi Mantra TSC?
What procedure was performed remotely using SSII's SSi Mantra Tele Surgeon Console?
How far apart were the surgeon and patient in SSII's first telesurgery?
What are the key features of the SSi Mantra Tele Surgeon Console (TSC)?
How does the SSi Mantra TSC change where telesurgeries can be performed for SSII (SSII)?
When was the SSi Mantra TSC first showcased before the October 2025 telesurgery?
